TrialThe Lancet. Oncology2017

Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial.

Robert Glynne-Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.